Acidic fibroblast growth factor intracellular-binding protein isoform a (169-179)

Acidic fibroblast growth factor intracellular-binding protein isoform a (169-179) is a synthetic peptide fragment corresponding to residues 169 through 179 of the intracellular-binding protein associated with acidic fibroblast growth factor (aFGF). This peptide represents a specific region of the binding protein implicated in modulating the intracellular trafficking, localization, and functional regulation of aFGF. As a research tool, it offers a targeted approach to dissecting protein-protein interactions, post-translational modifications, and signaling pathways relevant to growth factor biology. Its defined sequence and structural features make it valuable for in vitro and in vivo studies aiming to elucidate the molecular mechanisms underlying fibroblast growth factor signaling and its broader impact on cellular physiology.

Protein-protein interaction studies: The peptide segment enables precise investigation of the binding interfaces between aFGF and its intracellular partners. By serving as a competitive inhibitor or as a labeled probe in pull-down assays, it assists in mapping the critical residues responsible for complex formation. This targeted approach aids in clarifying the specificity and affinity of interactions, facilitating the identification of novel regulatory proteins or cofactors involved in aFGF-mediated signaling cascades.

Peptide mapping and epitope characterization: Researchers utilize this defined fragment for epitope mapping, allowing the identification of antibody recognition sites or functional domains within the aFGF-binding protein. Such studies are essential for the generation of specific antibodies and for understanding immune recognition mechanisms, which are crucial in both basic research and the development of analytical reagents for detection and quantification of related proteins.

Cell signaling pathway analysis: The synthetic peptide is applied in cellular models to probe the functional consequences of disrupting or mimicking the natural interactions of the aFGF-binding protein. By introducing the peptide into cell lysates or live cells, scientists can observe downstream effects on signaling pathways, phosphorylation events, and gene expression profiles. These insights contribute to a deeper understanding of the regulatory networks governing cell proliferation, differentiation, and survival in response to fibroblast growth factor stimuli.

Peptide-based assay development: The fragment serves as a reference standard or substrate in the design and optimization of biochemical assays, such as enzyme-linked immunosorbent assays (ELISAs), fluorescence polarization, or surface plasmon resonance studies. Its defined sequence allows for reproducible assay calibration and validation, supporting high-throughput screening endeavors and the quantitative analysis of protein interactions or modifications in complex biological samples.

Structural and biophysical studies: The peptide is employed in structural biology applications, including nuclear magnetic resonance (NMR) spectroscopy and circular dichroism (CD) analysis, to elucidate secondary structure elements and conformational dynamics. These studies provide foundational data on the flexibility, folding, and interaction propensity of the binding domain, informing models of protein architecture and guiding the rational design of modulators targeting the aFGF signaling axis.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. Extended exenatide administration enhances lipid metabolism and exacerbates pancreatic injury in mice on a high fat, high carbohydrate diet

4. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis